Skip to main content
BMRN logo

BioMarin Pharmaceutical Inc.

BMRNNASDAQHealthcareBiotechnology

$56.63Today:- (-)1Y +3.81%

As of Oct 22, 2026 close

Market cap
$10.99B
P/E (TTM)
150.67
Forward P/E
303.16
Dividend yield
-
52-week range
$49.26$70.98
Volume (live)
-
Avg. volume (3M)
2.32M

BioMarin Pharmaceutical Inc. (BMRN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for BioMarin Pharmaceutical Inc. stock.

Analyst Consensus Rating

Investment consensus from 26 professional research analysts

Consensus Rating

Buy
Based on 26 unique analysts
(38 total ratings in last 90 days)
Very High Confidence19.0:1 Buy/Sell

Average Price Target

$93.05
+64.31% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BMRN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Whitney Ijem
Canaccord Genuity
BuyMaintains
$114.00
Joon Lee
UBS
BuyReiterates
$114.00 → $88.00
Eliana Merle
Barclays
BuyMaintains
$111.00 → $114.00
Jason Gerberry
BofA Securities
BuyMaintains
$86.00
Luca Issi
RBC Capital
HoldMaintains
$62.00
Luca Issi
RBC Capital
HoldMaintains
$62.00
David Lebowitz
BMO Capital
BuyMaintains
$97.00
David Lebowitz
BMO Capital
BuyMaintains
$97.00
Jessica Fye
JP Morgan
BuyMaintains
$86.00
Debjit Chattopadhyay
Guggenheim
BuyMaintains
$86.00
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-
Debjit Chattopadhyay
Guggenheim
BuyMaintains
$86.00
Sean Laaman
Morgan Stanley
BuyReiterates
$124.00
David Lebowitz
BMO Capital
BuyReiterates
$98.00 → $97.00
Eric Joseph
Citi
BuyReiterates
-
Mohit Bansal
Wells Fargo
BuyMaintains
$80.00
Mitchell Kapoor
HC Wainwright
HoldReiterates
$60.00
Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
Olivia Brayer
Cantor Fitzgerald
BuyMaintains
$85.00 → $86.00
Allison Bratzel
Piper Sandler
BuyMaintains
$88.00 → $90.00
Salveen Richter
Goldman Sachs
HoldMaintains
$70.00
Paul Matteis
Stifel Nicolaus
HoldMaintains
$70.00
Whitney Ijem
Canaccord Genuity
BuyMaintains
$114.00
Sami Corwin
William Blair
HoldMaintains
-
Akash Tewari
Jefferies
BuyMaintains
$104.00 → $105.00
Salveen Richter
Goldman Sachs
HoldMaintains
$70.00
Mohit Bansal
Wells Fargo
BuyMaintains
$80.00
Phil Nadeau
TD Cowen
BuyMaintains
$120.00
Yun Zhong
Wedbush
BuyMaintains
$94.00
Jason Gerberry
BofA Securities
BuyMaintains
$86.00
David Lebowitz
BMO Capital
BuyInitiates
$98.00
Eliana Merle
Barclays
BuyMaintains
$105.00 → $111.00
Kinjel Shah
Zacks Equity Research
BuyInitiates Coverage
-
Leland Gershell
Oppenheimer
BuyInitiates Coverage
$95.00 → $97.00
Christopher Raymond
Raymond James
BuyMaintains
$100.00 → $105.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Luca Issi
RBC Capital
HoldMaintains
$62.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$120.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 16, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BMRN?

The analyst consensus rating for BMRN is Buy, based on the latest ratings from 26 analysts over the last 90 days.

What is the average price target for BMRN?

The average 12-month price target for BMRN is $93.05, representing an upside of 64.3% from the Oct 22, 2026 close of $56.63.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.